M. Buckwalter

发表

Pharmacokinetics of Gemtuzumab Ozogamicin as a Single‐Agent Treatment of Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia

J. Korth-Bradley, B. Gorovits, J. Dowell, 2004, Journal of clinical pharmacology.

Pharmacokinetics of Dalbavancin in Patients With Renal or Hepatic Impairment

T. Marbury, J. Dowell, M. Buckwalter, 2009, Journal of clinical pharmacology.

Population-based pharmacokinetics of the soluble TNFr etanercept: a clinical study in 43 patients with ankylosing spondylitis compared with post hoc data from patients with rheumatoid arthritis.

J. Boni, J. Wajdula, S. Fatenejad, 2004, International journal of clinical pharmacology and therapeutics.

Population Pharmacokinetic Analysis and Simulation of the Time‐Concentration Profile of Etanercept in Pediatric Patients With Juvenile Rheumatoid Arthritis

I. Nestorov, C. Peck, D. Yim, 2005, Journal of clinical pharmacology.

Single- and Multiple-Dose Pharmacokinetics of Methylphenidate Administered as Methylphenidate Transdermal System or Osmotic-Release Oral System Methylphenidate to Children and Adolescents With Attention Deficit Hyperactivity Disorder

D. Pierce, A. Katic, K. Webster, 2010, Journal of clinical psychopharmacology.

Pharmacokinetic‐Pharmacodynamic Modeling of Dalbavancin, a Novel Glycopeptide Antibiotic

B. Goldstein, B. Damle, M. Stogniew, 2008, Journal of clinical pharmacology.

Population Pharmacokinetic Analysis of Dalbavancin, a Novel Lipoglycopeptide

J. Dowell, M. Buckwalter, 2005, Journal of clinical pharmacology.

Pharmacokinetics of dalbavancin in plasma and skin blister fluid.

D. Nicolau, J. Dowell, M. Buckwalter, 2007, The Journal of antimicrobial chemotherapy.

Effects of Omeprazole on the Pharmacokinetic Profiles of Lisdexamfetamine Dimesylate and Extended-Release Mixed Amphetamine Salts in Adults

K. Lasseter, Patrick Martin, R. Homolka, 2009, Postgraduate medicine.

Absence of a Pharmacokinetic Interaction between Etanercept and Warfarin

A. Patat, Honghui Zhou, J. Korth-Bradley, 2004, Journal of clinical pharmacology.

Intranasal versus Oral Administration of Lisdexamfetamine Dimesylate

Patrick Martin, R. Page, E. Sandefer, 2011, Clinical drug investigation.

Lisdexamfetamine Dimesylate: Linear Dose‐Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open‐Label Single‐Dose Pharmacokinetic Study in Healthy Adult Volunteers

Patrick Martin, R. Homolka, J. Ermer, 2010, Journal of clinical pharmacology.